Íomhá chlúdaigh

Formulation and development of paediatric orally disintegrating carbamazepine tablets

Carbamazepine is a medicine used to manage epilepsy and partial or tonic-clonic seizures. This study aimed at formulating and obtaining carbamazepine orodispersible tablets for paediatric use at a 50 mg dose, with a diameter not greater than 6 mm and a tablet weight of 80 mg, through a direct compre...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	R Canadell-Heredia (Údar), M Suñé-Pou (Údar), A Nardi-Ricart (Údar), P Pérez-Lozano (Údar), JM Suñé-Negre (Údar), E García-Montoya (Údar)
Formáid:	LEABHAR
Foilsithe / Cruthaithe:	Elsevier, 2022-11-01T00:00:00Z.
Ábhair:	article
Rochtain ar líne:	Connect to this object online.
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Development of a Carvedilol Oral Liquid Formulation for Paediatric Use
de réir: Blanca Chiclana-Rodríguez, et al.
Foilsithe / Cruthaithe: (2023)

Robustness Optimization of an Existing Tablet Coating Process Applying Retrospective Knowledge (rQbD) and Validation
de réir: Albert Galí, et al.
Foilsithe / Cruthaithe: (2020)

Palatability and Stability Studies to Optimize a Carvedilol Oral Liquid Formulation for Pediatric Use
de réir: Blanca Chiclana-Rodríguez, et al.
Foilsithe / Cruthaithe: (2023)

Excipients in the Paediatric Population: A Review
de réir: Khadija Rouaz, et al.
Foilsithe / Cruthaithe: (2021)

Application of Galenic Strategies for Developing Gastro-Resistant Omeprazole Formulation for Pediatrics
de réir: Khadija Rouaz-, et al.
Foilsithe / Cruthaithe: (2024)

Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone's Particle Size on Sustained Release
de réir: Anna Nardi-Ricart, et al.
Foilsithe / Cruthaithe: (2020)

Methods for Developing a Process Design Space Using Retrospective Data
de réir: Miquel Romero-Obon, et al.
Foilsithe / Cruthaithe: (2023)

Optimisation of the Manufacturing Process of Organic-Solvent-Free Omeprazole Enteric Pellets for the Paediatric Population: Full Factorial Design
de réir: Khadija Rouaz-, et al.
Foilsithe / Cruthaithe: (2023)

Development of a Standardized Method for Measuring Bioadhesion and Mucoadhesion That Is Applicable to Various Pharmaceutical Dosage Forms
de réir: Lola Amorós-Galicia, et al.
Foilsithe / Cruthaithe: (2022)

Formulation and evaluation of orally disintegrating clopidogrel tablets
de réir: Gamal Mohamed Mahrous, et al.

Formulation of Chewable Tablets Containing Carbamazepine-β-cyclodextrin Inclusion Complex and F-Melt Disintegration Excipient. The Mathematical Modeling of the Release Kinetics of Carbamazepine
de réir: Adina Magdalena Musuc, et al.
Foilsithe / Cruthaithe: (2021)

Formulation and in vitro Evaluations of Paracetamol Orally Disintegrating Tablets
de réir: Azmiera Azimuddin, et al.
Foilsithe / Cruthaithe: (2023)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
de réir: Gailute Draksiene, et al.
Foilsithe / Cruthaithe: (2021)

Predicting oral disintegrating tablet formulations by neural network techniques
de réir: Run Han, et al.
Foilsithe / Cruthaithe: (2018)

SeDeM as a Tool to Validate Drug Substance Manufacturing Processes and Assess Scalability and Suitability for Direct Compression: Supplier Screening
de réir: Alba Figuera-Figuera, et al.
Foilsithe / Cruthaithe: (2023)

Comparative Analysis of the Physicochemical and Biological Characteristics of Freeze-Dried PEGylated Cationic Solid Lipid Nanoparticles
de réir: David A. Narváez-Narváez, et al.
Foilsithe / Cruthaithe: (2023)

Formulation and Characterisation of Carbamazepine Orodispersible 3D-Printed Mini-Tablets for Paediatric Use
de réir: Jiayu Hu, et al.
Foilsithe / Cruthaithe: (2023)

Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations
de réir: Dilawar Khan, et al.
Foilsithe / Cruthaithe: (2021)

Formulation and evaluation of orally disintegrating tablet of Rizatriptan using natural superdisintegrant
de réir: Tabbakhian Majid, et al.
Foilsithe / Cruthaithe: (2014)

Formulation and evaluation of orally disintegrating tablet of ondansetron using natural superdisintegrant
de réir: Shahtalebi Mohammad Ali, et al.
Foilsithe / Cruthaithe: (2015)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
de réir: Maimoona Chinwala
Foilsithe / Cruthaithe: (2020)

Formulation and evaluation of fast disintegrating tablet of glimepiride
de réir: Arooj Khalid, et al.
Foilsithe / Cruthaithe: (2018)

Orally disintegrating tablet: formulation design and optimisation using Response Surface Methodology
de réir: Biljana Nestorovska-Gjosevska, et al.
Foilsithe / Cruthaithe: (2005)

The Influence of Formulation and Manufacturing Process Parameters on the Characteristics of Lyophilized Orally Disintegrating Tablets
de réir: Marina Levina, et al.
Foilsithe / Cruthaithe: (2011)

Orally Disintegrating Tablet Formulation of Avicennia Fruit Ethanol Extract (Avicennia marina)
de réir: Ungsari Rizki Eka Purwanto, et al.
Foilsithe / Cruthaithe: (2021)

Development and Evaluation of Ondansetron Orally Disintegrating Tablets
de réir: Bipin Pustake, et al.
Foilsithe / Cruthaithe: (2019)

Development and evaluation of ofloxacin orally disintegrating tablets
de réir: Badrinath Pralhadrao Mohite, et al.
Foilsithe / Cruthaithe: (2012)

A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
de réir: Essam A. Tawfik, et al.
Foilsithe / Cruthaithe: (2021)

Factors Affecting the Formulation of Carbamazepine Extended Release Tablet
de réir: Samer H. Aziz, et al.
Foilsithe / Cruthaithe: (2017)

Factors Affecting the Formulation of Carbamazepine Extended Release Tablet
de réir: Samer H. Aziz, et al.
Foilsithe / Cruthaithe: (2017)

Application of Design of Experiment for development of orally disintegrating tablets
de réir: Irina Ermolina, et al.
Foilsithe / Cruthaithe: (2023)

Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy
de réir: Yoshihisa Yamamoto, et al.
Foilsithe / Cruthaithe: (2023)

Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
de réir: Ekapol Limpongsa, et al.
Foilsithe / Cruthaithe: (2022)

Captopril fast disintegrating tablets for children: formulation and quality control by HPLC
de réir: Shohreh Alipour, et al.
Foilsithe / Cruthaithe: (2017)

Rivaroxaban solid dispersions for dissolution enhancement and formulation of mouth disintegrating tablets
de réir: Kalki Ranjan Priyadarshan, et al.
Foilsithe / Cruthaithe: (2024)

Captopril fast disintegrating tablets for children: formulation and quality control by HPLC
de réir: Shohreh Alipour, et al.
Foilsithe / Cruthaithe: (2017)

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
de réir: Hesham M. Tawfeek, et al.
Foilsithe / Cruthaithe: (2020)

Optimized furosemide taste masked orally disintegrating tablets
de réir: Mohamed Abbas Ibrahim, et al.
Foilsithe / Cruthaithe: (2017)

A data-driven approach utilizing a raw material database and machine learning tools to predict the disintegration time of orally fast-disintegrating tablet formulations
de réir: Navyaja Kota, et al.
Foilsithe / Cruthaithe: (2024)

compressional force in disintegration of tablets containing disintegrants of different mechanisms
de réir: Chakri Thongplengsri
Foilsithe / Cruthaithe: (2013)